|
CA2564249A1
|
|
Indole and azaindole derivatives with antitumor action
|
|
WO2005092314A1
|
|
4-oxo-fenretinide, administered alone and in combination with fenretinide, as preventive and therapeutic agent for cancer
|
|
NZ531808A
|
|
Apparatus for the characterisation of pigmented skin lesions using means to obtain images of the lesions and a neural network
|
|
US2007148644A1
|
|
Method for the detection of cancer
|
|
EP1560848A2
|
|
Ptprk immunogenic peptide
|
|
EP1454992A1
|
|
Anaplastic lymphoma kinase assay, reagents and compositions thereof
|
|
AU2003208771A1
|
|
Modified human manganese superoxide dismutase and uses thereof
|
|
WO0185784A2
|
|
POLYNUCLEOTIDES ENCODING FOR POLYMORPHIC ISOFORMS OF THE PTHrP PROTEIN, THE ENCODED PROTEINS AND THEIR THERAPEUTIC APPLICATIONS THEREOF
|
|
GC0000200A
|
|
Camptothecin derivatives having antitumor activity
|
|
CA2247513A1
|
|
Camptothecin derivatives and the use thereof as antitumor agents
|
|
ITMI960338A1
|
|
CAMPTOTECIN DERIVATIVES AND THEIR USE AS ANTI-CANCER AGENTS
|
|
ITMI951315D0
|
|
Compounds having anti-tumoural activity
|
|
KR100270465B1
|
|
Pharmaceutical composition comprising 4'-iodo-4'-deoxydoxorubicin for the treatment of amyloidosis
|
|
EP0627226A1
|
|
Coated stent
|
|
NZ267086A
|
|
Ngf receptor ntrk1 gene-containing neuronal cells
|
|
CA2162677A1
|
|
Expression of ntrk1-derived oncogenes in pc12 pheochromocytoma cells and use thereof for the screening of anti-tyrosine kinase compounds
|
|
ITMI931800A1
|
|
Use of 4'-deoxy-4'-iododoxorubicin for the treatment of amyloidosis
|
|
US6231855B1
|
|
Monoclonal antibodies as antidotes for anthracycline antibiotics
|
|
IL104985D0
|
|
Protein compound,coding nucleotide sequences,producing cell line and uses thereof
|
|
EP0630404A1
|
|
Protein compound capable of inhibiting tumoral growth
|
